showed a trendP =0.005
Analyses restricted to stage III showed a trend towards a shorter RFS in KRAS -mutated ( P =0.005), BRAF wt ( P =0.009) and pMMR tumours ( P =0.036).
Analyses restricted to stage III showed a trend towards a shorter RFS in KRAS -mutated ( P =0.005), BRAF wt ( P =0.009) and pMMR tumours ( P =0.036).